CardioTech

From WikiCover

CardioTech International develops advanced polymer materials and manufacturer of medical products for the treatment and diagnosis of a broad range of disease states. CardioTech's business model leverages its proprietary materials science technology and manufacturing expertise in order to expand its product sales and royalty and license fee income. It develops next generation polymers and manufactures new and complex medical devices to customers' unique specifications. CardioTech is conducting its first clinical trial for regulatory approval in Europe for its CardioPass synthetic coronary bypass graft.

Website: http://www.cardiotech-inc.com/